Shepherd Street Advisors LLC Purchases Shares of 1,945 Intuitive Surgical, Inc. $ISRG

Shepherd Street Advisors LLC purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 1,945 shares of the medical equipment provider’s stock, valued at approximately $1,102,000.

Other institutional investors have also recently made changes to their positions in the company. Newbridge Financial Services Group Inc. grew its position in shares of Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 33 shares during the last quarter. Holos Integrated Wealth LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $25,000. Olistico Wealth LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $28,000. Laurel Wealth Advisors LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $31,000. Finally, Turning Point Benefit Group Inc. lifted its stake in shares of Intuitive Surgical by 833.3% in the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after purchasing an additional 50 shares during the period. Institutional investors own 83.64% of the company’s stock.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Negative Sentiment: Deutsche Bank cut its price target on Intuitive Surgical (ISRG) to $366 from $440 and kept a sell rating, reinforcing concerns that the stock may have further downside from current levels. MarketScreener article
• Negative Sentiment: Company SVP Iman Jeddi sold 5,625 shares in a pre-arranged 10b5-1 plan, a transaction that can still weigh on sentiment because it reduces insider ownership and may signal caution to some investors.
• Neutral Sentiment: Several articles highlighted that ISRG is a highly watched and frequently traded name, but these pieces were mostly informational and did not present a new catalyst. Zacks article
• Neutral Sentiment: Analysts and commentary also pointed to Intuitive Surgical’s AI-driven digital roadmap and connected da Vinci ecosystem as a potential long-term growth driver, but that story appears to be offset today by valuation and rating concerns. Yahoo Finance article

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amy L. Ladd sold 500 shares of the company’s stock in a transaction that occurred on Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total transaction of $236,730.00. Following the transaction, the director directly owned 239 shares of the company’s stock, valued at approximately $113,156.94. This represents a 67.66% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the transaction, the senior vice president directly owned 6,463 shares in the company, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 8,096 shares of company stock worth $3,545,294 in the last quarter. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG stock opened at $402.30 on Wednesday. The stock’s 50 day simple moving average is $452.19 and its 200 day simple moving average is $504.81. Intuitive Surgical, Inc. has a fifty-two week low of $396.68 and a fifty-two week high of $603.88. The company has a market cap of $142.48 billion, a P/E ratio of 48.76, a price-to-earnings-growth ratio of 3.29 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. During the same period in the prior year, the business earned $1.81 EPS. The firm’s revenue for the quarter was up 23.0% on a year-over-year basis. Equities analysts predict that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Analyst Ratings Changes

ISRG has been the topic of a number of recent analyst reports. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 30th. JPMorgan Chase & Co. dropped their price objective on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Argus dropped their price objective on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research note on Wednesday, February 4th. Bank of America dropped their price objective on Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating on the stock in a research note on Monday, May 18th. Finally, BTIG Research reissued a “buy” rating and issued a $574.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, April 22nd. Nineteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $573.63.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.